Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Names Labsco US Hospital Distributor

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid today announced that Labsco has been named a US distribution partner for its GeneXpert Systems and tests.

Labsco has exclusive US distribution rights to sell the Cepheid products to acute care hospitals with less than 150 beds. The deal does not include Cepheid's higher-throughput GeneXpert Infinity System, the Sunnyvale, Calif.-based molecular diagnostics firm said.

Louisville, Ky.-based Labsco also has received non-exclusive rights to the non-acute care, non-hospital market, which would include surgical centers affiliated with hospitals, independent surgical centers, physicians' offices labs, group practices, and nursing homes.

"There are more than 3,900 US hospitals with less than 150 beds which have not been a primary focus of Cepheid to date," Nico Arnold, executive vice president of worldwide operations for Cepheid, said in a statement. "The decision to engage on a nationwide basis with Labsco is in line with one of our strategic growth objectives directed at expanding our reach within the US market."

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.